Âé¶¹´«Ã½

Fears for the future

Nigel Poole head of external regulatory affairs at Zeneca Plant Science in
Bracknell, Berkshire:

“Britain could be classed as number two in biotechnology in the world, after
the US, but it’s clinging on by its fingertips. These witch-hunts are crazy. I
feel quite emotional about this at the moment. We still believe in the UK, but
God knows why.â€

George Poste chief science and technology officer with the Anglo-American
drugs giant SmithKline Beecham, based in Philadelphia:

“The hysteria we’ve seen can be used as a springboard to go after other
aspects of gene research. Press and public opinion influence legislation and
legislation influences whether a company invests. The overall climate of
tolerance for extremes of the anti-technological movement is taken into
²¹³¦³¦´Ç³Ü²Ô³Ù.â€

Chris Evans founder of Merlin Ventures and Britain’s leading biotech
entrepreneur:

“We’re collectively being demonised as Frankenstein’s assistants. It’s
becoming silly, like Salem witch-hunts. We must raise money, but people who buy
shares are affected by what they read. It could limit options for raising funds
for the medical side of the industry.â€

Bill Fullagar president of the British arm of the Swiss-based multinational
Novartis, a major producer of pharmaceuticals and GM crops:

“Anything like what we’ve seen go on in the last week must put pressure on
the authorities. This can lead to decisions that stop companies from investing.
We are a global company. Britain is not the only place where you can do
research: there’s the whole of North America and the whole of Europe.â€

Jeremy Curnock Cook head of the Rothschild Bioscience Unit in London,
responsible for funds worth some $500 million:

“It will harm investment in the UK. Ultimately, investors don’t differentiate
between the elements of the sector. No one will care whether it’s GM crops or
³ó±ð²¹±ô³Ù³ó³¦²¹°ù±ð.â€

Topics: Food and drink / Genetics

More from Âé¶¹´«Ã½

Explore the latest news, articles and features